Clinical impact of positron emission tomography (PET) with (18F)fluorodeoxyglucose (FDG) in head and neck tumours

By Ekberg Tomas   Sörensen Jens   Engström Mats   Blomquist Erik   Sundin Anders   Anniko Matti  

Acta Oto-Laryngologica, Vol. 127, Iss. 2, 2007-01 ,pp. : 186-193

Informa Healthcare

Access to resources Recommend Favorite

Positron emission tomography using [¹⁸F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?

By Brouwer Jolijn   Bree Remco   Comans Emile   Castelijns Jonas   Hoekstra Otto   Leemans C.  

European Archives of Oto-Rhino-Laryngology, Vol. 261, Iss. 9, 2004-10 ,pp. : 479-483

Springer Publishing Company

Access to resources Recommend Favorite

[Fluorine-18]Fluorodeoxyglucose Positron Emission Tomography, DNA Ploidy and Growth Fraction in Squamous-Cell Carcinomas of the Head and Neck

By  

ORL, Vol. 63, Iss. 5, 2001-08 ,pp. : 307-313

Karger

Access to resources Recommend Favorite

Preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography imaging in head and neck cancer: does it really improve initial N staging?

By Richard Celine   Prevot Nathalie   Timoshenko Andrei P.   Dumollard Jean-Marc   Dubois Francis   Martin Christian   Prades Jean-Michel  

Acta Oto-Laryngologica, Vol. 130, Iss. 12, 2010-12 ,pp. : 1421-1424

Informa Healthcare

Access to resources Recommend Favorite

Impact of positron emission tomography with the use of fluorodeoxyglucose on response to induction chemotherapy in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma

By Kawakita Daisuke  

Acta Oto-Laryngologica, Vol. 133, Iss. 5, 2013-05 ,pp. : 523-530

Informa Healthcare

Access to resources Recommend Favorite